Long-term follow-up of vertebral osteoporotic fractures treated by percutaneous vertebroplasty
- 18 May 2004
- journal article
- clinical trial
- Published by Springer Nature in Clinical Rheumatology
- Vol. 23 (4) , 310-317
- https://doi.org/10.1007/s10067-004-0914-7
Abstract
The aim of this study was:to assess the long-term efficacy and safety of percutaneous vertebroplasty (PVP) for treating painful vertebral osteoporotic fractures, and to estimate the risk of vertebral fracture in the vicinity of a cemented vertebra. A prospective open study was conducted. PVP were carried out between July 1995 and September 2000 for 16 patients with symptomatic osteoporotic vertebral fracture that had not responded to extensive conservative medical therapy. All the patients were followed-up for more than 1 year. The efficacy of the PVP was assessed by the changes over time in pain on Huskisson’s visual analog scale (VAS) and on the McGill-Melzack scoring system (MGM). The efficacy of the procedure was also assessed by measuring the changes over time in quality of life assessed by the Nottingham Health Profile (NHP instrument): twenty-one vertebrae treated by PVP in 16 patients were evaluated. The mean duration of follow-up was 35 months. Pain assessed by the VAS significantly decreased from a mean of 71.4 mm±13 before PVP to 36 mm±30 after 6 months, and to 39 mm±33 at the time of maximal follow-up (pp<0.05). The solely statistically significant decrease for quality of life was noted for pain. A slight but not significant improvement was noted for 3/6 dimensions of the NHP scores. A slight but significant increase in social isolation was also found. No severe complication occurred immediately after PVP. At the long term follow-up (35 months) there was a slight but not significantly increased risk of vertebral fracture in the vicinity of a cemented vertebra: odds ratio 3.18 (95% confidence interval (CI) 0.51–19.64). The odds ratio of a vertebral fracture in the vicinity of an uncemented fractured vertebra was 2.14 (95% CI: 0.17–26.31). In conclusion, PVP appears to be safe and effective for treating persistent painful osteoporotic fractures. Controlled studies with long-term follow-up are needed to evaluate the risk of vertebral fractures in the vicinity of a cemented vertebra.Keywords
This publication has 27 references indexed in Scilit:
- Evaluation of spinal curvatures after a recent osteoporotic vertebral fractureJoint Bone Spine, 2002
- Should percutaneous vertebroplasty be used to treat osteoporotic fractures? An updateJoint Bone Spine, 2001
- Percutaneous transpedicular vertebroplasty with PMMA: operative technique and early resultsEuropean Spine Journal, 2000
- Acute osteoporotic vertebral collapse: open study on percutaneous injection of acrylic surgical cement in 20 patients.American Journal of Roentgenology, 1999
- PERCUTANEOUS VERTEBROPLASTY WITH POLYMETHYLMETHACRYLATERadiologic Clinics of North America, 1998
- Percutaneous vertebroplasty: state of the art.RadioGraphics, 1998
- Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up.Radiology, 1996
- Spinal metastases: indications for and results of percutaneous injection of acrylic surgical cement.Radiology, 1996
- Vertebral fracture assessment using a semiquantitative techniqueJournal of Bone and Mineral Research, 1993
- CT and MRI of ruptured intracranial dermoidsNeuroradiology, 1991